JP2008527032A5 - - Google Patents

Download PDF

Info

Publication number
JP2008527032A5
JP2008527032A5 JP2007551738A JP2007551738A JP2008527032A5 JP 2008527032 A5 JP2008527032 A5 JP 2008527032A5 JP 2007551738 A JP2007551738 A JP 2007551738A JP 2007551738 A JP2007551738 A JP 2007551738A JP 2008527032 A5 JP2008527032 A5 JP 2008527032A5
Authority
JP
Japan
Prior art keywords
synthase
leukotriene
activating protein
family members
lipoxygenase activating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007551738A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008527032A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2006/000188 external-priority patent/WO2006077412A1/en
Publication of JP2008527032A publication Critical patent/JP2008527032A/ja
Publication of JP2008527032A5 publication Critical patent/JP2008527032A5/ja
Withdrawn legal-status Critical Current

Links

JP2007551738A 2005-01-19 2006-01-19 炎症の治療に有用なチエノピロール Withdrawn JP2008527032A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64455905P 2005-01-19 2005-01-19
PCT/GB2006/000188 WO2006077412A1 (en) 2005-01-19 2006-01-19 Thienopyrroles useful in the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2008527032A JP2008527032A (ja) 2008-07-24
JP2008527032A5 true JP2008527032A5 (https=) 2009-04-02

Family

ID=34956613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007551738A Withdrawn JP2008527032A (ja) 2005-01-19 2006-01-19 炎症の治療に有用なチエノピロール

Country Status (5)

Country Link
US (1) US20090069384A1 (https=)
EP (1) EP1844051A1 (https=)
JP (1) JP2008527032A (https=)
CA (1) CA2594665A1 (https=)
WO (1) WO2006077412A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007517056A (ja) 2003-12-29 2007-06-28 セプラコア インコーポレーテッド ピロール及びピラゾールdaao阻害剤
JP2008527030A (ja) * 2005-01-19 2008-07-24 バイオリポックス エービー 炎症の治療に有用なインドール類
BRPI0519774A2 (pt) 2005-01-19 2009-02-10 Biolipox Ab composto ou um sal farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, mÉtodo de tratamento de uma doenÇa em que inibiÇço da atividade de um membro da famÍlia mapeg É desejada e/ou necessÁria, produto combinado, e, processo para a preparaÇço de um composto
US20070203111A1 (en) 2006-01-06 2007-08-30 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
NZ569608A (en) 2006-01-06 2011-09-30 Sepracor Inc Tetralone-based monoamine reuptake inhibitors
CN101421228B (zh) 2006-03-31 2014-05-21 塞普拉柯公司 手性酰胺和胺的制备
US7579370B2 (en) 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
CA2659060A1 (en) * 2006-06-30 2008-01-10 Sepracor Inc. Fused heterocyclic inhibitors of d-amino acid oxidase
EP2077267A4 (en) 2006-10-18 2010-04-07 Takeda Pharmaceutical CONDENSED HETEROCYCLIC COMPOUND
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
CA2688493C (en) 2007-05-31 2016-04-19 Sepracor Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
US20120029016A1 (en) 2008-12-30 2012-02-02 Biolipox Ab Indoles Useful in the Treatment of Inflammation
EA201290089A1 (ru) 2009-09-04 2012-09-28 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Химические соединения
US20110152243A1 (en) * 2009-12-23 2011-06-23 Abbott Laboratories Novel thienopyrrole compounds
GB201006846D0 (en) 2010-04-23 2010-06-09 Glaxo Group Ltd Novel compounds
ES2568455T3 (es) 2010-06-01 2016-04-29 Summit Therapeutics Plc Compuestos para el tratamiento de enfermedad asociada a Clostridium difficile
GB2480815A (en) * 2010-06-01 2011-12-07 Summit Corp Plc Compounds for the treatment of clostridium difficile-associated disease
EP2993175A1 (en) 2014-09-05 2016-03-09 IEO - Istituto Europeo di Oncologia Srl Thienopyrroles as histone demethylase inhibitors
EP3246330A1 (en) 2016-05-18 2017-11-22 Istituto Europeo di Oncologia S.r.l. Imidazoles as histone demethylase inhibitors
AU2017275657B2 (en) 2016-06-02 2021-08-19 Novartis Ag Potassium channel modulators
PL3571193T3 (pl) 2017-01-23 2022-04-25 Cadent Therapeutics, Inc. Modulatory kanału potasowego
EP3870291A1 (en) 2018-10-22 2021-09-01 Cadent Therapeutics, Inc. Crystalline forms of potassium channel modulators
KR20240056747A (ko) * 2021-09-10 2024-04-30 길리애드 사이언시즈, 인코포레이티드 티에노피롤 화합물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081138A (en) * 1986-12-17 1992-01-14 Merck Frosst Canada, Inc. 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5374615A (en) * 1990-10-31 1994-12-20 E. R. Squibb & Sons, Inc. Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5294722A (en) * 1992-04-16 1994-03-15 E. R. Squibb & Sons, Inc. Process for the preparation of imidazoles useful in angiotensin II antagonism
US5236916A (en) * 1992-05-26 1993-08-17 E. R. Squibb & Sons, Inc. Oxadiazinone substituted indole and benzimidazole derivatives
TW229140B (https=) * 1992-06-05 1994-09-01 Shell Internat Res Schappej B V
JPH10510510A (ja) * 1994-06-09 1998-10-13 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗物質
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
HU227568B1 (en) * 1997-12-24 2011-08-29 Sanofi Aventis Deutschland Indole derivatives, as inhibitors os factor xa
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
US6828344B1 (en) * 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) * 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
JP2001069477A (ja) * 1999-08-31 2001-03-16 Sony Corp 番組提供システム及び番組提供方法
US6353007B1 (en) * 2000-07-13 2002-03-05 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
PL366068A1 (en) * 2000-10-10 2005-01-24 Smithkline Beecham Corporation Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents
US6630786B2 (en) * 2001-03-30 2003-10-07 Candescent Technologies Corporation Light-emitting device having light-reflective layer formed with, or/and adjacent to, material that enhances device performance

Similar Documents

Publication Publication Date Title
JP2008527032A5 (https=)
JP2008527031A5 (https=)
JP2008527027A5 (https=)
JP2008527028A5 (https=)
JP2008527030A5 (https=)
CY2016017I1 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
WO2008118379A3 (en) AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
WO2008055068A8 (en) Inhibitors of histone deacetylase
PL3050571T3 (pl) Preparat enzymu trawiennego do leczenia rzucawki
WO2009155001A3 (en) Wnt protein signalling inhibitors
WO2008011557A3 (en) Heteroaryl inhibitors of rho kinase
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
NO345119B1 (no) Fremgangsmåte for å forhindre og/eller hemme dannelse av uorganiske fluoridavsetninger
WO2008048991A3 (en) Organic compounds
SMP200900058B (it) Composti e composizioni come inibitori di proteinachinasi.
SM201000108A (it) Composti e composizioni come inibitori di proteinachinasi.
WO2007120574A3 (en) Diaryl substituted alkanes
WO2007126957A3 (en) New compounds
LT2894165T (lt) Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
EA200801897A1 (ru) Ингибиторы mnk2 на основе 8-гетероарилпурина для лечения метаболических нарушений
SMAP201000118A (it) Composto di ossimetilene arile e loro utilizzo.
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
BRPI0808422A2 (pt) Compostos orgânicos bicíclicos adequados para o tratamento de condições inflamatórias ou alérgicas
WO2009064486A3 (en) Inhibitors of pim protein kinases, compositions, and methods for treating cancer
WO2009046842A3 (de) Thialzolderivate zur behandlung von krebs